Cargando…
18F-FDG-PET/MR in Alveolar Echinococcosis: Multiparametric Imaging in a Real-World Setting
Recent improvements in alveolar echinococcosis (AE) therapy can provide long-term disease control, and even allow structured treatment interruption in selected cases. Imaging has a pivotal role in monitoring disease activity, with 18-fluoro-deoxyglucose positron emission and computed tomography (18F...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951377/ https://www.ncbi.nlm.nih.gov/pubmed/35335672 http://dx.doi.org/10.3390/pathogens11030348 |
_version_ | 1784675371121115136 |
---|---|
author | Eberhardt, Nina Peters, Lynn Kapp-Schwoerer, Silke Beer, Meinrad Beer, Ambros J. Grüner, Beate Thaiss, Wolfgang M. |
author_facet | Eberhardt, Nina Peters, Lynn Kapp-Schwoerer, Silke Beer, Meinrad Beer, Ambros J. Grüner, Beate Thaiss, Wolfgang M. |
author_sort | Eberhardt, Nina |
collection | PubMed |
description | Recent improvements in alveolar echinococcosis (AE) therapy can provide long-term disease control, and even allow structured treatment interruption in selected cases. Imaging has a pivotal role in monitoring disease activity, with 18-fluoro-deoxyglucose positron emission and computed tomography (18F-FDG-PET/CT) in particular having proven beneficial for assessing disease activity. Repetitive regular examinations to monitor therapy response, however, can lead to substantial radiation burden. Therefore, by combining metabolic information and excellent tissue contrast in magnetic resonance imaging (MRI), PET/MR appears ideally suited for this task. Here, we retrospectively analyzed 51 AE patients that underwent 18F-FDG-PET/MR. Patients had a ‘confirmed/probable’ diagnosis in 22/29 cases according to the WHO classification. FDG uptake, diffusion restriction, and MRI morphology were evaluated. We found significant differences in FDG uptake between responders to benzimidazole therapy and progressive manifestations (SUVavg 2.7 ± 1.3 vs. 5.4 ± 2.2, p < 0.001) as well as between Kodama Types 1 and 3 (F = 9.9, p < 0.003). No significant differences were detected for ADC values or MRI morphology concerning response and no correlations were present between FDG uptake and ADC values. The mean radiation dose was 5.9–6.5 mSv. We conclude that the combination of metabolic information and MRI morphology at a low radiation dose proposes PET/MR as a suitable imaging modality for AE assessment. Longitudinal studies are needed to define the role of this imaging modality. |
format | Online Article Text |
id | pubmed-8951377 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89513772022-03-26 18F-FDG-PET/MR in Alveolar Echinococcosis: Multiparametric Imaging in a Real-World Setting Eberhardt, Nina Peters, Lynn Kapp-Schwoerer, Silke Beer, Meinrad Beer, Ambros J. Grüner, Beate Thaiss, Wolfgang M. Pathogens Article Recent improvements in alveolar echinococcosis (AE) therapy can provide long-term disease control, and even allow structured treatment interruption in selected cases. Imaging has a pivotal role in monitoring disease activity, with 18-fluoro-deoxyglucose positron emission and computed tomography (18F-FDG-PET/CT) in particular having proven beneficial for assessing disease activity. Repetitive regular examinations to monitor therapy response, however, can lead to substantial radiation burden. Therefore, by combining metabolic information and excellent tissue contrast in magnetic resonance imaging (MRI), PET/MR appears ideally suited for this task. Here, we retrospectively analyzed 51 AE patients that underwent 18F-FDG-PET/MR. Patients had a ‘confirmed/probable’ diagnosis in 22/29 cases according to the WHO classification. FDG uptake, diffusion restriction, and MRI morphology were evaluated. We found significant differences in FDG uptake between responders to benzimidazole therapy and progressive manifestations (SUVavg 2.7 ± 1.3 vs. 5.4 ± 2.2, p < 0.001) as well as between Kodama Types 1 and 3 (F = 9.9, p < 0.003). No significant differences were detected for ADC values or MRI morphology concerning response and no correlations were present between FDG uptake and ADC values. The mean radiation dose was 5.9–6.5 mSv. We conclude that the combination of metabolic information and MRI morphology at a low radiation dose proposes PET/MR as a suitable imaging modality for AE assessment. Longitudinal studies are needed to define the role of this imaging modality. MDPI 2022-03-12 /pmc/articles/PMC8951377/ /pubmed/35335672 http://dx.doi.org/10.3390/pathogens11030348 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Eberhardt, Nina Peters, Lynn Kapp-Schwoerer, Silke Beer, Meinrad Beer, Ambros J. Grüner, Beate Thaiss, Wolfgang M. 18F-FDG-PET/MR in Alveolar Echinococcosis: Multiparametric Imaging in a Real-World Setting |
title | 18F-FDG-PET/MR in Alveolar Echinococcosis: Multiparametric Imaging in a Real-World Setting |
title_full | 18F-FDG-PET/MR in Alveolar Echinococcosis: Multiparametric Imaging in a Real-World Setting |
title_fullStr | 18F-FDG-PET/MR in Alveolar Echinococcosis: Multiparametric Imaging in a Real-World Setting |
title_full_unstemmed | 18F-FDG-PET/MR in Alveolar Echinococcosis: Multiparametric Imaging in a Real-World Setting |
title_short | 18F-FDG-PET/MR in Alveolar Echinococcosis: Multiparametric Imaging in a Real-World Setting |
title_sort | 18f-fdg-pet/mr in alveolar echinococcosis: multiparametric imaging in a real-world setting |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951377/ https://www.ncbi.nlm.nih.gov/pubmed/35335672 http://dx.doi.org/10.3390/pathogens11030348 |
work_keys_str_mv | AT eberhardtnina 18ffdgpetmrinalveolarechinococcosismultiparametricimaginginarealworldsetting AT peterslynn 18ffdgpetmrinalveolarechinococcosismultiparametricimaginginarealworldsetting AT kappschwoerersilke 18ffdgpetmrinalveolarechinococcosismultiparametricimaginginarealworldsetting AT beermeinrad 18ffdgpetmrinalveolarechinococcosismultiparametricimaginginarealworldsetting AT beerambrosj 18ffdgpetmrinalveolarechinococcosismultiparametricimaginginarealworldsetting AT grunerbeate 18ffdgpetmrinalveolarechinococcosismultiparametricimaginginarealworldsetting AT thaisswolfgangm 18ffdgpetmrinalveolarechinococcosismultiparametricimaginginarealworldsetting |